Back to Search
Start Over
A literature review and case reports series on the use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction
- Source :
- International Journal of STD & AIDS. 20:152-157
- Publication Year :
- 2009
- Publisher :
- SAGE Publications, 2009.
-
Abstract
- Summary The term ‘female sexual dysfunction’ (FSD) encompasses a number of different disorders, and while their aetiologies are not fully understood, the sub-classifications of this broad umbrella term are increasingly becoming more established and accepted. However, there is less consensus regarding the optimal treatment of these conditions. While it is known that phosphodiesterase (PDE5) is involved in the female sexual response, the clinical and research evidence supporting the unlicensed use of PDE5 inhibitors (PDE5i) in women is inconclusive and at times contradictory. In this article we explore this further by means of a comprehensive literature review on the use of PDE5i in the treatment of FSD and we also present our clinical experience of using these drugs in this context.
- Subjects :
- Adult
Sexually transmitted disease
medicine.medical_specialty
Phosphodiesterase Inhibitors
Female sexual dysfunction
MEDLINE
Umbrella term
Context (language use)
Dermatology
Pharmacotherapy
Internal medicine
medicine
Humans
Pharmacology (medical)
Sexual Dysfunctions, Psychological
business.industry
Public Health, Environmental and Occupational Health
Phosphodiesterase
Middle Aged
medicine.disease
Sexual Dysfunction, Physiological
Infectious Diseases
Endocrinology
Sexual dysfunction
Female
medicine.symptom
business
Clinical psychology
Subjects
Details
- ISSN :
- 17581052 and 09564624
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- International Journal of STD & AIDS
- Accession number :
- edsair.doi.dedup.....66e9d2548a866bcbdb47d332a66141ba
- Full Text :
- https://doi.org/10.1258/ijsa.2008.008336